In myotubes in vitro, the silencing of Hsp90 or STAT3 protects from the atrophy induced by C26 cancer cell conditional media (C26‐CM) and decreases the expression of Atrogin‐1, Myostatin and MuRF1. The gene discussed is HSP90AA1; the disease is cancer.